Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Umbilical cord blood–derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect

Claudio G. Brunstein, Jeffrey S. Miller, David H. McKenna, Keli L. Hippen, Todd E. DeFor, Darin Sumstad, Julie Curtsinger, Michael R. Verneris, Margaret L. MacMillan, Bruce L. Levine, James L. Riley, Carl H. June, Chap Le, Daniel J. Weisdorf, Philip B. McGlave, Bruce R. Blazar, John E. Wagner

Blood (2016) 127 (8): 1044–1051.

https://doi.org/10.1182/blood-2015-06-653667

Published: 2016

Includes: Supplemental data

Journal Articles

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics

Claudio G. Brunstein, Jeffrey S. Miller, Qing Cao, David H. McKenna, Keli L. Hippen, Julie Curtsinger, Todd DeFor, Bruce L. Levine, Carl H. June, Pablo Rubinstein, Philip B. McGlave, Bruce R. Blazar, John E. Wagner

Blood (2011) 117 (3): 1061–1070.

https://doi.org/10.1182/blood-2010-07-293795

Published: 2011

Includes: Supplemental data

Journal Articles

Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units

Michael R. Verneris, Claudio G. Brunstein, Juliet Barker, Margaret L. MacMillan, Todd DeFor, David H. McKenna, Michael J. Burke, Bruce R. Blazar, Jeffrey S. Miller, Philip B. McGlave, Daniel J. Weisdorf, John E. Wagner

Blood (2009) 114 (19): 4293–4299.

https://doi.org/10.1182/blood-2009-05-220525

Published: 2009

Journal Articles

Favorable Leukemia-Free Survival (LFS) for Adults and Children Undergoing Myeloablative Umbilical Cord Blood (UCB) Transplantation with Cyclophosphamide (CY), Fludarabine (FLU) and Total Body Irradiation (TBI): A Single Center Analysis of 194 Patients.

Claudio Brunstein, MD, PhD, Daniel Weisdorf, Todd DeFor, Jeffrey S. Miller, MD, Philip B. McGlave, Bruce R. Blazar, MD, John E. Wagner, MD

Blood (2008) 112 (11): 1957.

https://doi.org/10.1182/blood.V112.11.1957.1957

Published: 2008

Journal Articles

Successful Haploidentical Hematopoietic Cell Engraftment Using a Non-Myeloablative Preparative Regimen Including Natural Killer (NK) Cells

Sarah Cooley, Purvi Gada, David McKenna, Valarie McCullar, Susan Fautsch, Michael Verneris, Bruce R Blazar, Linda J Burns, Philip B McGlave, MD, Daniel J. Weisdorf, Jeffrey S Miller

Blood (2008) 112 (11): 827.

https://doi.org/10.1182/blood.V112.11.827.827

Published: 2008

Journal Articles

Negative Effect of KIR Alloreactivity in Recipients of Umbilical Cord Blood Transplantation Depends on Transplantation Conditioning Intensity

Claudio Brunstein, MD, PhD, John E. Wagner, MD, Daniel Weisdorf, MD, Sarah Cooley, MD, Harriet Noreen, Juliet Barker, MBBS, Todd DeFor, Michael Verneris, MD, Philip B. McGlave, Bruce R. Blazar, MD, Jeffrey S. Miller, MD

Blood (2008) 112 (11): 152.

https://doi.org/10.1182/blood.V112.11.152.152

Published: 2008

Journal Articles

Encouraging Results of Reduced Intensity Conditioning (RIC) Umbilical Cord Blood (UCB) Transplantation for the Treatment of Advanced Lymphoid Malignancies.

Claudio G. Brunstein, MD, Susana Cantero, MD, Qing Cao, MS, Navneet Majhail, MD, Brian McClune, DO, Linda J. Burns, MD, Marcie Tomblyn, MD, Jeffrey S. Miller, MD, Bruce R. Blazar, MD, Philip B. McGlave, MD, Daniel J. Weisdorf, MD, John E. Wagner, MD

Blood (2007) 110 (11): 2028.

https://doi.org/10.1182/blood.V110.11.2028.2028

Published: 2007

Journal Articles

The Predictive Value of the Hematopoietic Cell Transplantation (HCT)-Specific Comorbidity Index (CI) in Recipients of Umbilical Cord Blood (UCB) Transplantation.

Claudio G. Brunstein, MD, PhD, Navneet Majhail, MD, MS, Daniela C. Setubal, MD, Todd E. DeFor, MS, Jeffrey S. Miller, MD, Philip B. McGlave, MD, Bruce R. Blazar, MD, Daniel J. Weisdorf, MD, John E. Wagner, MD

Blood (2007) 110 (11): 5065.

https://doi.org/10.1182/blood.V110.11.5065.5065

Published: 2007

Journal Articles

Reduced Intensity Allogeneic Transplant in Patients Older Than 55 Years: Unrelated Umbilical Cord Blood Is Safe and Effective for Patients without a Matched Related Donor.

Navneet S. Majhail, Claudio Brunstein, John E. Wagner, Marcie Tomblyn, Avis Thomas, Jeffrey S. Miller, Mukta Arora, Dan S. Kaufman, Linda J. Burns, Arne Slungaard, Philip B. McGlave, Daniel J. Weisdorf

Blood (2007) 110 (11): 331.

https://doi.org/10.1182/blood.V110.11.331.331

Published: 2007

Journal Articles

Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study

Smita Bhatia, Liton Francisco, Andrea Carter, Can-Lan Sun, K. Scott Baker, James G. Gurney, Philip B. McGlave, Auayporn Nademanee, Margaret O'Donnell, Norma K. C. Ramsay, Leslie L. Robison, David Snyder, Anthony Stein, Stephen J. Forman, Daniel J. Weisdorf

Blood (2007) 110 (10): 3784–3792.

https://doi.org/10.1182/blood-2007-03-082933

Published: 2007

Journal Articles

Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease

Claudio G. Brunstein, Juliet N. Barker, Daniel J. Weisdorf, Todd E. DeFor, Jeffrey S. Miller, Bruce R. Blazar, Philip B. McGlave, John E. Wagner

Blood (2007) 110 (8): 3064–3070.

https://doi.org/10.1182/blood-2007-04-067215

Published: 2007

Journal Articles

A Novel Triple Umbilical Cord Blood Transplant (UCBT) Strategy To Promote NK Cell Immunotherapy (Unit 1) with a Fully Ablative Preparative Regimen Followed by a Double UCBT in Patients with Refractory AML.

Jeffrey S. Miller, MD, Claudio G. Brunstein, MD, Sarah Cooley, MD, Michael R. Verneris, MD, Angela Panoskaltsis-Mortari, MD, Linda J. Burns, MD, David McKenna, MD, Kathryn Dusenbery, MD, Cladd Stevens, MD, Pablo Rubensten, MD, Marcie Tomblyn, MD, Mukta Arora, MD, Margaret L. MacMillan, MD, Todd DeFor, PhD, Chap Le, PhD, Philip B. McGlave, MD, Bruce R. Blazar, MD, Daniel J. Weisdorf, MD

Blood (2006) 108 (11): 3111.

https://doi.org/10.1182/blood.V108.11.3111.3111

Published: 2006

Journal Articles

Optimal NK Cell Expansion Depends on Accessory Cells, Synergy between Physiologic Concentrations of IL-2 and IL-15, and Umbilical Cord Blood (UCB) NK Cell Precursors Expand Better Than Adult NK Cells.

Purvi Gada, MBBS, Michelle Gleason, Valarie McCullar, Philip B. McGlave, MD, Jeffrey S. Miller, MD

Blood (2006) 108 (11): 3642.

https://doi.org/10.1182/blood.V108.11.3642.3642

Published: 2006

Journal Articles

Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study

Smita Bhatia, Leslie L. Robison, Liton Francisco, Andrea Carter, Yan Liu, Marcia Grant, K. Scott Baker, Henry Fung, James G. Gurney, Philip B. McGlave, Auayporn Nademanee, Norma K. C. Ramsay, Anthony Stein, Daniel J. Weisdorf, Stephen J. Forman

Blood (2005) 105 (11): 4215–4222.

https://doi.org/10.1182/blood-2005-01-0035

Published: 2005

Journal Articles

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

Jeffrey S. Miller, Yvette Soignier, Angela Panoskaltsis-Mortari, Sarah A. McNearney, Gong H. Yun, Susan K. Fautsch, David McKenna, Chap Le, Todd E. Defor, Linda J. Burns, Paul J. Orchard, Bruce R. Blazar, John E. Wagner, Arne Slungaard, Daniel J. Weisdorf, Ian J. Okazaki, Philip B. McGlave

Blood (2005) 105 (8): 3051–3057.

https://doi.org/10.1182/blood-2004-07-2974

Published: 2005

Journal Articles

Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy

Juliet N. Barker, Daniel J. Weisdorf, Todd E. DeFor, Bruce R. Blazar, Philip B. McGlave, Jeffrey S. Miller, Catherine M. Verfaillie, John E. Wagner

Blood (2005) 105 (3): 1343–1347.

https://doi.org/10.1182/blood-2004-07-2717

Published: 2005

Journal Articles

Successful Remission of Poor Prognosis AML after Adoptive Transfer and In Vivo Expansion of Human Haploidentical NK Cells.

Jeffrey S. Miller, MD, Yvette Soignier, Angela Panosskaltsis-Mortari, PhD, David McKenna, MD, Chap Le, PhD, Todd E. Defor, PhD, Linda J. Burns, MD, Paul J. Orchard, MD, Bruce R. Blazar, MD, John E. Wagner, MD, Arne Slungaard, MD, Daniel J. Weisdorf, MD, Ian J. Okazaki, MD, Philip B. McGlave, MD

Blood (2004) 104 (11): 260.

https://doi.org/10.1182/blood.V104.11.260.260

Published: 2004

Journal Articles

Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study

K. Scott Baker, James G. Gurney, Kirsten K. Ness, Ravi Bhatia, Stephen J. Forman, Liton Francisco, Philip B. McGlave, Leslie L. Robison, David S. Snyder, Daniel J. Weisdorf, Smita Bhatia

Blood (2004) 104 (6): 1898–1906.

https://doi.org/10.1182/blood-2004-03-1010

Published: 2004

Journal Articles

Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the National Marrow Donor Program

Philip B. McGlave, Xiao Ou Shu, Wanqing Wen, Claudio Anasetti, Auayporn Nademanee, Richard Champlin, Joseph H. Antin, Nancy A. Kernan, Roberta King, Daniel J. Weisdorf

Blood (2000) 95 (7): 2219–2225.

https://doi.org/10.1182/blood.V95.7.2219

Published: 2000

Journal Articles

Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the International Bone Marrow Transplant Registry

Sergio Giralt, Richard Szydlo, John M. Goldman, Judy Veum-Stone, James C. Biggs, Roger H. Herzig, John P. Klein, Philip B. McGlave, Gary Schiller, Robert Peter Gale, Philip A. Rowlings, Mary M. Horowitz

Blood (2000) 95 (2): 410–415.

https://doi.org/10.1182/blood.V95.2.410

Published: 2000

NARROW

Umbilical cord blood–derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics

Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units

Favorable Leukemia-Free Survival (LFS) for Adults and Children Undergoing Myeloablative Umbilical Cord Blood (UCB) Transplantation with Cyclophosphamide (CY), Fludarabine (FLU) and Total Body Irradiation (TBI): A Single Center Analysis of 194 Patients.

Successful Haploidentical Hematopoietic Cell Engraftment Using a Non-Myeloablative Preparative Regimen Including Natural Killer (NK) Cells

Negative Effect of KIR Alloreactivity in Recipients of Umbilical Cord Blood Transplantation Depends on Transplantation Conditioning Intensity

Encouraging Results of Reduced Intensity Conditioning (RIC) Umbilical Cord Blood (UCB) Transplantation for the Treatment of Advanced Lymphoid Malignancies.

The Predictive Value of the Hematopoietic Cell Transplantation (HCT)-Specific Comorbidity Index (CI) in Recipients of Umbilical Cord Blood (UCB) Transplantation.

Reduced Intensity Allogeneic Transplant in Patients Older Than 55 Years: Unrelated Umbilical Cord Blood Is Safe and Effective for Patients without a Matched Related Donor.

Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study

Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease

A Novel Triple Umbilical Cord Blood Transplant (UCBT) Strategy To Promote NK Cell Immunotherapy (Unit 1) with a Fully Ablative Preparative Regimen Followed by a Double UCBT in Patients with Refractory AML.

Optimal NK Cell Expansion Depends on Accessory Cells, Synergy between Physiologic Concentrations of IL-2 and IL-15, and Umbilical Cord Blood (UCB) NK Cell Precursors Expand Better Than Adult NK Cells.

Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy

Successful Remission of Poor Prognosis AML after Adoptive Transfer and In Vivo Expansion of Human Haploidentical NK Cells.

Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study

Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the National Marrow Donor Program

Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the International Bone Marrow Transplant Registry

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only